Article
Induced pluripotent stem cells for cardiovascular disease: from product-focused disease modeling to process-focused disease discovery.
Regenerative medicine - 1 Jan 2015
Campbell Katherine A, Terzic Andre, Nelson Timothy J
Abstract excerpt
Induced pluripotent stem (iPS) cell technology offers an unprecedented opportunity to study patient-specific disease. This biotechnology platform enables recapitulation of individualized disease signatures in a dish through differentiation of patient-derived iPS cells. Beyond disease modeling, the in vitro process of differentiation toward genuine patient tissue offers a blueprint to inform disease etiology and...
Topics
- Animals
- Biotechnology
- Cardiovascular Diseases
- Cell Differentiation
- Cellular Reprogramming
- Disease Models, Animal
- Humans
- Induced Pluripotent Stem Cells
- Phenotype
- Regenerative Medicine
- Tissue Engineering
